Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical Journal

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20041598PMID 15595924PMCID PMC1134989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An overview of glucocorticoid anti-inflammatory actions

  2005cited by this paper
• Identification of a truncated ratp28-related protein expressed in kidney.

  2004cited by this paper
• Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells

  2004cited by this paper
• Management of cirrhosis and ascites.

  2004cited by this paper
• Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells

  2003cited by this paper
• Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells.

  2003cited by this paper
• Stem Cell Factor Attenuates Liver Damage in a Murine Model of Acetaminophen-Induced Hepatic Injury

  2003cited by this paper
• Gliotoxin Ameliorates Development of Fibrosis and Cirrhosis in a Thioacetamide Rat Model

  2003cited by this paper
• Transcription factors in liver development, differentiation, and regeneration

  2003cited by this paper
• Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model

  2003cited by this paper
• The role of hepatocytes and oval cells in liver regeneration and repopulation.

  2003cited by this paper
• Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro.

  2003cited by this paper
• Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.

  2003cited by this paper
• Mesenchymal cells in the liver--one cell type or two?

  2002cited by this paper
• PPAR alpha and the regulation of cell division and apoptosis.

  2002cited by this paper
• PPARα and the regulation of cell division and apoptosis

  2002cited by this paper
• Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis

  2001cited by this paper
• Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.

  2001cited by this paper
• The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

  2001cited by this paper
• Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.

  2001cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands*

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.

  2000cited by this paper
• Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.

  2000cited by this paper
• The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

  2000cited by this paper
• Peroxisome proliferator‐activated receptor γ transcriptional regulation is involved in platelet‐derived growth factor–induced proliferation of human hepatic stellate cells

  2000cited by this paper
• Liver regeneration.

  2000cited by this paper
• Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis.

  2000cited by this paper
• Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation*

  2000cited by this paper
• Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury

  1999cited by this paper
• P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

  1999cited by this paper
• The cytochrome P450 3A4 inducer metyrapone is an activator of the human pregnane X receptor.

  1999cited by this paper
• Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.

  1999cited by this paper
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

  1998cited by this paper
• Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole

  1998cited by this paper
• An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

  1998cited by this paper
• Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2.

  1997cited by this paper
• The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol.

  1996cited by this paper
• Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.

  1996cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor

  1995cited by this paper
• Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein.

  1994cited by this paper
• Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism.

  1984cited by this paper

• Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: Microbial-immune-metabolic network.

  2026cites this paper
• Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan

  2025cites this paper
• Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy

  2024cites this paper
• Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease.

  2024cites this paper
• Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by downregulating periostin expression.

  2024cites this paper
• Pregnane X receptor activation alleviates renal fibrosis in mice via interacting with p53 and inhibiting the Wnt7a/β-catenin signaling

  2023cites this paper
• Environmental endocrine disruptors and pregnane X receptor action: A review.

  2023cites this paper
• S10 | Pathology and adverse outcome pathways

  2023cites this paper
• Potential for cardiac toxicity with methylimidazolium ionic liquids

  2023cites this paper
• The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis

  2022cites this paper
• Nuclear Receptors in Liver Fibrosis.

  2021cites this paper
• Prevention of D-GalN/LPS-induced ALI by 18β-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation

  2021cites this paper
• Pregnane X Receptor and the Gut-Liver Axis: A Recent Update

  2021cites this paper
• Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?

  2021cites this paper
• The Role of Vitamin K in Cholestatic Liver Disease

  2021cites this paper
• The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver

  2021cites this paper
• Renal injury and hepatic effects from the methylimidazolium ionic liquid M8OI in mouse

  2020cites this paper
• Changes in the gut microbiota of mice orally exposed to methylimidazolium ionic liquids

  2020cites this paper
• Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis.

  2019cites this paper
• The association of pregnane X receptor activation with outcomes after liver transplantation—A retrospective study

  2019cites this paper
• Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis

  2018cites this paper
• Screening of Industrial and Agricultural Chemicals for Searching a Mouse PXR Activator Using Cell-Based Reporter Gene Assays

  2018cites this paper
• Glucocorticoid-induced pancreatic-hepatic trans-differentiation in a human cell line in vitro.

  2018cites this paper
• Insights into the development of peri-biliary fibrosis following hepatic ischaemia-reperfusion injury and the ameliorating effect of PXR activation

  2018cites this paper
• The stellate cell system (vitamin A-storing cell system)

  2017cites this paper
• Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse

  2017cites this paper
• Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice

  2017cites this paper
• Interacción colesterol-gangliósido GD3 en la fibrosis hepática

  2017cites this paper
• B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals

  2017cites this paper
• Targeting nuclear receptors for the treatment of fatty liver disease

  2017cites this paper
• Drug Discovery in Tissue Fibrosis

  2017cites this paper
• ABC Transporters Involved in Cholestasis

  2017cites this paper
• Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

  2016cites this paper
• Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture system.

  2016cites this paper
• Environmental Xenoestrogens Super-Activate a Variant Murine ER Beta in Cholangiocytes

  2016cites this paper
• Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1′-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism

  2016cites this paper
• Nonalcoholic fatty liver disease (NAFLD): emerging molecular targets for novel therapeutic strategies

  2016cites this paper
• Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation

  2015influential citation
• Dissecting fibrosis: therapeutic insights from the small-molecule toolbox

  2015cites this paper
• A reversible model for periportal fibrosis and a refined alternative to bile duct ligation

  2014cites this paper
• Utility of B-13 Progenitor-Derived Hepatocytes in Hepatotoxicity and Genotoxicity Studies

  2013cites this paper
• Pregnane X receptor polymorphisms associated with human diseases

  2013cites this paper
• Molecular Interactions between NAFLD and Xenobiotic Metabolism

  2013cites this paper
• Alcohol Cirrhosis Alters Nuclear Receptor and Drug Transporter Expression in Human Liver

  2013cites this paper
• Pregnane X receptor (PXR) at the crossroads of human metabolism and disease.

  2013cites this paper
• Pregnane X receptor and human malignancy.

  2013cites this paper
• Role of nuclear factor E2 related factor 2 (Nrf2) in development of steatosis and drug transporter alterations

  2013cites this paper
• Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

  2013cites this paper
• Activation of pregnane X receptor inhibits experimental dermal fibrosis

  2013cites this paper
• DMD049676 1148..1155

  2013cites this paper
• Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease

  2012cites this paper
• Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist.

  2012cites this paper
• Understanding the mechanisms regulating liver fibrosis (including the use of imaging techniques in its study and diagnosis)

  2012cites this paper
• Targeting the pregnane X receptor in liver injury

  2012cites this paper
• The role of xenoestrogens in the initiation of primary biliary cirrhosis

  2012cites this paper
• Roles of microRNA-29 a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells

  2011cites this paper
• Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis

  2011cites this paper
• MRP8/ABCC11 Expression Is Regulated by Dexamethasone in Breast Cancer Cells and Is Associated to Progesterone Receptor Status in Breast Tumors

  2011cites this paper
• Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells

  2011cites this paper
• Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes

  2011cites this paper
• Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.

  2011cites this paper
• Fibrogenesis in nonalcoholic steatohepatitis

  2011cites this paper
• Mechanisms of hepatic fibrogenesis.

  2011cites this paper
• Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.

  2010cites this paper
• Hepatic stellate cell (vitamin A‐storing cell) and its relative – past, present and future

  2010cites this paper
• The PXR is a drug target for chronic inflammatory liver disease

  2010cites this paper
• Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid.

  2010cites this paper
• Investigación de nuevas estrategias terapeúticas para la inflamación y la fibrosis hepática.

  2010cites this paper
• Nuclear Receptor Regulation of the Adaptive Response of Bile Acid Transporters in Cholestasis

  2010cites this paper
• Emerging molecular targets for the treatment of nonalcoholic fatty liver disease.

  2010cites this paper
• Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease

  2010cites this paper
• Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity.

  2010cites this paper
• Glucocorticoid-dependent transdifferentiation of pancreatic progenitor cells into hepatocytes is dependent on transient suppression of WNT signalling

  2010cites this paper
• The Protective Role of Pregnane X Receptor in Lipopolysaccharide/D-galactosamine-induced Acute Liver Injury

  2009cites this paper
• Nuclear receptors as therapeutic targets in cholestatic liver diseases

  2009cites this paper
• Exocrine pancreas trans-differentiation to hepatocytes--a physiological response to elevated glucocorticoid in vivo.

  2009cites this paper
• Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.

  2009cites this paper
• Transcriptional regulation of hepatic stellate cells.

  2009cites this paper
• Regulation of the Pregnane X Receptor Signaling Pathway

  2009cites this paper
• Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics

  2009cites this paper
• Elucidating the ‘Jekyll and Hyde’ Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists

  2009cites this paper
• Nuclear receptor ligands in therapy of cholestatic liver disease.

  2009cites this paper
• Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells

  2009cites this paper
• Induction of drug metabolism : role for nuclear receptors

  2008cites this paper
• Hepatic fibrosis -- overview.

  2008cites this paper
• Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.

  2008influential citation
• Liver fibrosis.

  2008cites this paper
• Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary Atresia

  2008cites this paper
• Mechanisms of hepatic fibrogenesis.

  2008cites this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cites this paper
• Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential.

  2008cites this paper
• Cytokines and renin-angiotensin system signaling in hepatic fibrosis.

  2008cites this paper
• Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy

  2008cites this paper
• A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB?

  2008cites this paper
• The pregnane X receptor: from bench to bedside

  2008cites this paper
• PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics.

  2008cites this paper
• Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.

  2007cites this paper
• SXR, A Novel Target for Breast Cancer Therapeutics

  2007cites this paper
• Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

  2007cites this paper
• Expression of CYP2S1 in human hepatic stellate cells

  2007cites this paper